Nabumetone
NDC 50228-465, Nabumetone, tablet, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-465
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-465 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NABUMETONE500 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-465-01 | 50228046501 | 100 TABLET in 1 BOTTLE (50228-465-01) |
| 50228-465-05 | 50228046505 | 500 TABLET in 1 BOTTLE (50228-465-05) |
| 50228-465-30 | 50228046530 | 30 TABLET in 1 BOTTLE (50228-465-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/80c6888d-03b4-44f3-b94d-bcf5154ceae5NADAC price for package 50228046501
GET /v1/drugs/nadac/50228046501NADAC price for package 50228046505
GET /v1/drugs/nadac/50228046505
Use it
Look up 50228-465 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-465 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-465. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.